1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Possible clinical outcome predictors for interlaminar ESI at short-term follow-upa
Improvement (n = 63) No Improvement (n = 18) P Value Ageb 50 ± 13.5 49.6 ± 17.6 .914 Sex Male 10 (62.5%) 6 (37.5%) .175 Female 53 (81.5%) 12 (18.5%) Duration of LBP <3 Months 32 (78.0%) 9 (22.0%) 1.000 >3 months 31 (77.5%) 9 (22.5%)
a Data are number of patients.
b Mean age (years).